Cargando…
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
Breast cancer (BC) is a heterogeneous disease where the survival rate of patients decreases with progression of the disease. BC usually has a linear progression, classified into normal/benign, atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC). Th...
Autores principales: | Kothari, Charu, Ouellette, Geneviève, Labrie, Yvan, Jacob, Simon, Diorio, Caroline, Durocher, Francine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324778/ https://www.ncbi.nlm.nih.gov/pubmed/30647841 http://dx.doi.org/10.18632/oncotarget.26448 |
Ejemplares similares
-
Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families
por: Pouliot, Marie-Christine, et al.
Publicado: (2017) -
The Importance of Breast Adipose Tissue in Breast Cancer
por: Kothari, Charu, et al.
Publicado: (2020) -
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
por: Kothari, Charu, et al.
Publicado: (2021) -
TBC1D9: An Important Modulator of Tumorigenesis in Breast Cancer
por: Kothari, Charu, et al.
Publicado: (2021) -
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines
por: Burguin, Anna, et al.
Publicado: (2020)